Digitek-Brand Digoxin Tablets Are Recalled
Posted on: Monday, 28 April 2008, 12:00 CDT
The U.S. Food and Drug Administration announced the recall of Digitek-brand digoxin heart tablets because of a potential safety risk.
The FDA said Actavis Totowa LLC, formerly known as Amide Pharmaceutical Inc. of Totowa, N.J., reported some tablets may be double the appropriate thickness and contain twice the approved level of active ingredient.
The products are distributed by Mylan Pharmaceuticals Inc. under a Bertek label and by UDL Laboratories Inc. under a UDL label.
Digitek is used to treat heart failure and abnormal heart rhythms. The existence of double-strength tablets poses a risk of digitalis toxicity in patients with renal failure and can cause nausea, vomiting, dizziness, low blood pressure, cardiac instability and bradycardia. Death can also result from excessive Digitalis intake.
Customers with questions can call 888-276-6166.
The FDA said any adverse reactions experienced with the use of the product should also be reported to the its MedWatch Program at 800-332-1088.
Source: United Press International
Related Articles
- Adding Lipitor Early to Effective Blood Pressure Treatment Provided a Significant Reduction in Heart Attacks or Deaths From Heart Attacks Over Five Years
- Abbott OK'D on Niaspan Coated Tablet
- King's Altace OK'D in Tablet Form
- MultiVu Video Feed: Intensive Lipitor Therapy Cuts The Risk of Hospitalizations Due to Heart Failure in Patients With Coronary Heart Disease, New Analysis Shows
- GSK Wins Approval for Extended Release Heart Drug
- E-Tablets Help Treat Patients -- While Waiting, Clients Answer Symptom Inquiries on Devices
- FDA Approves AstraZeneca's ATACAND(R) (Candesartan Cilexetil) for Use With an ACE Inhibitor in the Treatment of Heart Failure
- Diet Can Circumvent Heart Disease
- Viagra Saved My Life ; And the Side-Effects Aren't Bad Either, Says Man Told to Take Three Tablets a Day to Treat a Heart Condition
 |
 |
User Comments (0)
RSS Feeds